Literature DB >> 18485677

The omp50 gene is transcriptionally controlled by a temperature-dependent mechanism conserved among thermophilic Campylobacter species.

Luc Dedieu1, Jean-Marie Pagès, Jean-Michel Bolla.   

Abstract

The thermophilic Campylobacters are enteropathogenic for humans. We recently showed that Omp50 is a Campylobacter species-specific porin produced in Campylobacter jejuni and Campylobacter lari but not in Campylobacter coli. In the present study, we investigated regulation of the omp50 gene and found that its expression in C. jejuni was temperature-dependent, but independent of growth phase or medium viscosity. The use of RT-PCR and omp50::lacZ fusions showed that growth temperature control occurred at the transcriptional level. The promoter and the coding sequence were cloned in an Escherichia coli-Campylobacter shuttle plasmid and transferred to E. coli and to a C. jejuni Omp50-deficient strain. Regulation of omp50 gene expression by growth temperature was observed in the recombinant C. jejuni strain, but not in E. coli. The same regulation was also observed in wild-type C. lari strains and in a C. coli strain supplemented by the plasmid, suggesting that omp50 expression is controlled by a mechanism conserved among Campylobacter species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485677     DOI: 10.1016/j.resmic.2008.03.002

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  5 in total

Review 1.  EnvZ/OmpR Two-Component Signaling: An Archetype System That Can Function Noncanonically.

Authors:  Linda J Kenney; Ganesh S Anand
Journal:  EcoSal Plus       Date:  2020-01

2.  Peptide translocation across MOMP, the major outer membrane channel from Campylobacter jejuni.

Authors:  Naresh Niranjan Dhanasekar; Soumeya Aliouane; Mathias Winterhalter; Jean-Marie Pagès; Jean-Michel Bolla
Journal:  Biochem Biophys Rep       Date:  2017-06-23

3.  Antibacterial Mode of Action of the Daucus carota Essential Oil Active Compounds against Campylobacter jejuni and Efflux-Mediated Drug Resistance in Gram-Negative Bacteria.

Authors:  Dedieu Luc; Brunel Jean Michel; Lorenzi Vanina; Muselli Alain; Berti Liliane; Bolla Jean Michel
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

4.  Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment.

Authors:  Qingqing Xia; Wayne T Muraoka; Zhangqi Shen; Orhan Sahin; Hongning Wang; Zuowei Wu; Peng Liu; Qijing Zhang
Journal:  BMC Microbiol       Date:  2013-06-14       Impact factor: 3.605

Review 5.  Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing.

Authors:  Abdi Elmi; Fauzy Nasher; Nick Dorrell; Brendan Wren; Ozan Gundogdu
Journal:  Front Cell Infect Microbiol       Date:  2021-02-03       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.